Related Experiment Videos
FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms
Martin Siewert1, Jennifer Dressman, Cynthia K Brown
1Aventis, Frankfurt, Germany. martin.siewert@aventis.com
AAPS Pharmscitech
|August 15, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High-throughput screening of amorphous solid dispersions: a systematic approach to enhance bioaccessibility of a poorly soluble drug.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Biowaiver monograph for immediate-release solid oral dosage forms: Amlodipine besylate.
Journal of pharmaceutical sciences·2025
Biowaiver monograph for immediate-release solid oral dosage forms: Empagliflozin.
Journal of pharmaceutical sciences·2025
Combining high-throughput ASD screening with the rDCS to streamline development of poorly soluble drugs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: Paving the road towards fed state virtual BE studies for itraconazole amorphous solid dispersions.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Development of discriminatory and biopredictive bicarbonate buffer based dissolution method to screen delayed release formulations.
Drug development and industrial pharmacy·2026
Span60/Cholesterol Niosomal Formulation as a Transport Vehicle for L-DOPA and Rasagiline Delivery with Potent In Vitro Neuroprotective Effect.
Applied biochemistry and biotechnology·2026
Evaluating Powder Deposition in the Nasal Airways Using a Facile Fluorescent-Imaging Method.
Journal of aerosol medicine and pulmonary drug delivery·2026